In a boost for health innovation, APR.Intern and the recently established ARC Centre for Personalised Therapeutics Technologies (ARC CPTT) have partnered to place 24 of the Centre’s skilled PhDs into short-term 3-5 month research projects over four years.
With over 500 Australian MedTech companies already in operation and skill demand growing, the ARC CPTT aims to foster supply of PhDs with both the research and industry skills to drive product research and development, and oversee regulatory affairs which are required for future growth of the sector.
“A core mission for our Centre and APR.Intern, this partnership opens critical avenues to provide PhDs with essential experiential industry training helping to future proof the biomedical workforce,” says ARC Centre for Personalised Therapeutics Technologies Director, Professor Alastair Stewart.
A collaboration between the University of Melbourne, Monash University, the University of Western Australia and 15 partner organisations, the ARC Centre for Personalised Therapeutics Technologies aims to improve technology enabling the selection of therapies and ability to fast track their progression to clinical trial.
With a focus on accelerating women in STEM, these internships will contribute to placements to be delivered by APR.Intern under the Australian Government’s $28.2 million Supporting more women in STEM careers: Australian Mathematical Sciences Institute (AMSI)—National Research Internship Program (NRIP).
Standard eligibility requirements apply.
$15K – PHD STUDENT AT $3K PER MONTH
$5.5K – ACADEMIC MENTOR PAYMENT
$5.5K – ADMINISTRATION COST PROJECT MANAGEMENT
*50% REBATE AVAILABLE, ELIGIBLE ORGANISATIONS PAY ONLY $13K
This program is supported by the Australian Government Department of Education and Training, through the ‘Supporting more women in STEM careers: Australian Mathematical Sciences Institute (AMSI) – National Research Internships Program’.